{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:03:39Z","timestamp":1792713819174,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T00:00:00Z","timestamp":1541635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T00:00:00Z","timestamp":1541635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2017M3A9G2077885"],"award-info":[{"award-number":["NRF-2017M3A9G2077885"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2017M3A9G2077885"],"award-info":[{"award-number":["NRF-2017M3A9G2077885"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2014R1A6A3A04058006"],"award-info":[{"award-number":["NRF-2014R1A6A3A04058006"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["H16C0094"],"award-info":[{"award-number":["H16C0094"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["H16C0094"],"award-info":[{"award-number":["H16C0094"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["H16C0094"],"award-info":[{"award-number":["H16C0094"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["H16C0094"],"award-info":[{"award-number":["H16C0094"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["H16C0094"],"award-info":[{"award-number":["H16C0094"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although rapamycin is a well-known conformational inhibitor of mTORC1, it is now widely used for treating arterial restenosis. Various rapamycin analogues (rapalogue) have been made for applying to drug-eluting stents. Here we show that two major rapalogues, everolimus and biolimus, exert a differential effect on the mTORC1-mediated signaling pathways in vascular smooth muscle cells. In balloon-injured carotid arteries, both rapalogues strongly inhibit neointimal hyperplasia. Signaling pathway analyses reveal that everolimus exert cytotoxicity by increasing cellular reactive oxygen species and consequently reduce energy metabolism. By contrast, biolimus confers a preferential induction of autophagy by more strongly activating major autophagy regulator, ULK1, in vascular smooth muscle cells than everolimus does. As a consequence, the implantation of biolimus-eluting stent reduces endothelial loss, which in turn reduces inflammation, in porcine coronary arteries. Thus, this study reveals that a chemical derivatization can cause a change among mTORC1-dependent signaling pathways in vascular smooth muscle cells, thereby enabling to elicit a differential efficacy on arterial restenosis.<\/jats:p>","DOI":"10.1038\/s41598-018-34877-8","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T12:00:22Z","timestamp":1541160022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A rapamycin derivative, biolimus, preferentially activates autophagy in vascular smooth muscle cells"],"prefix":"10.1038","volume":"8","author":[{"given":"Yerin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Hyuk","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Seung","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Seob","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Won","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,8]]},"reference":[{"key":"34877_CR1","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1161\/01.CIR.0000078025.19258.28","volume":"107","author":"PA Lemos","year":"2003","unstructured":"Lemos, P. A., Serruys, P. W. & Sousa, J. E. Drug-eluting stents: cost versus clinical benefit. Circulation 107, 3003\u20133007, https:\/\/doi.org\/10.1161\/01.CIR.0000078025.19258.28 (2003).","journal-title":"Circulation"},{"key":"34877_CR2","doi-asserted-by":"publisher","first-page":"24C","DOI":"10.1016\/0002-9149(91)90220-F","volume":"68","author":"B Cercek","year":"1991","unstructured":"Cercek, B., Sharifi, B., Barath, P., Bailey, L. & Forrester, J. S. Growth factors in pathogenesis of coronary arterial restenosis. Am J Cardiol 68, 24C\u201333C (1991).","journal-title":"Am J Cardiol"},{"key":"34877_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/CIRCINTERVENTIONS.110.957332","volume":"4","author":"SO Marx","year":"2011","unstructured":"Marx, S. O., Totary-Jain, H. & Marks, A. R. Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv 4, 104\u2013111, https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.110.957332 (2011).","journal-title":"Circ Cardiovasc Interv"},{"key":"34877_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/01.CIR.103.2.192","volume":"103","author":"JE Sousa","year":"2001","unstructured":"Sousa, J. E. et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103, 192\u2013195 (2001).","journal-title":"Circulation"},{"key":"34877_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1139\/y77-007","volume":"55","author":"RR Martel","year":"1977","unstructured":"Martel, R. R., Klicius, J. & Galet, S. Inhibition of the immune response by rapamycin, a new antifungal antibiotic. Can J Physiol Pharmacol 55, 48\u201351 (1977).","journal-title":"Can J Physiol Pharmacol"},{"key":"34877_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/0277-5379(83)90012-3","volume":"19","author":"DP Houchens","year":"1983","unstructured":"Houchens, D. P., Ovejera, A. A., Riblet, S. M. & Slagel, D. E. Human brain tumor xenografts in nude mice as a chemotherapy model. Eur J Cancer Clin Oncol 19, 799\u2013805 (1983).","journal-title":"Eur J Cancer Clin Oncol"},{"key":"34877_CR7","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/369756a0","volume":"369","author":"EJ Brown","year":"1994","unstructured":"Brown, E. J. et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369, 756\u2013758, https:\/\/doi.org\/10.1038\/369756a0 (1994).","journal-title":"Nature"},{"key":"34877_CR8","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1126\/science.1715094","volume":"253","author":"J Heitman","year":"1991","unstructured":"Heitman, J., Movva, N. R. & Hall, M. N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253, 905\u2013909 (1991).","journal-title":"Science"},{"key":"34877_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0092-8674(00)00117-3","volume":"103","author":"T Schmelzle","year":"2000","unstructured":"Schmelzle, T. & Hall, M. N. TOR, a central controller of cell growth. Cell 103, 253\u2013262 (2000).","journal-title":"Cell"},{"key":"34877_CR10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante, M. & Sabatini, D. M. mTOR signaling in growth control and disease. Cell 149, 274\u2013293, https:\/\/doi.org\/10.1016\/j.cell.2012.03.017 (2012).","journal-title":"Cell"},{"key":"34877_CR11","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nrd3531","volume":"10","author":"D Benjamin","year":"2011","unstructured":"Benjamin, D., Colombi, M., Moroni, C. & Hall, M. N. Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat Rev Drug Discov 10, 868\u2013880, https:\/\/doi.org\/10.1038\/nrd3531 (2011).","journal-title":"Nat Rev Drug Discov"},{"key":"34877_CR12","doi-asserted-by":"publisher","first-page":"1236566","DOI":"10.1126\/science.1236566","volume":"341","author":"SA Kang","year":"2013","unstructured":"Kang, S. A. et al. mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin. Science 341, 1236566, https:\/\/doi.org\/10.1126\/science.1236566 (2013).","journal-title":"Science"},{"key":"34877_CR13","doi-asserted-by":"publisher","first-page":"17414","DOI":"10.1073\/pnas.0809136105","volume":"105","author":"AY Choo","year":"2008","unstructured":"Choo, A. Y., Yoon, S. O., Kim, S. G., Roux, P. P. & Blenis, J. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc Natl Acad Sci USA 105, 17414\u201317419, https:\/\/doi.org\/10.1073\/pnas.0809136105 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"34877_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20110892","volume":"441","author":"B Magnuson","year":"2012","unstructured":"Magnuson, B., Ekim, B. & Fingar, D. C. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J 441, 1\u201321, https:\/\/doi.org\/10.1042\/BJ20110892 (2012).","journal-title":"Biochem J"},{"key":"34877_CR15","doi-asserted-by":"publisher","first-page":"11591","DOI":"10.1074\/jbc.M110367200","volume":"277","author":"TP Herbert","year":"2002","unstructured":"Herbert, T. P., Tee, A. R. & Proud, C. G. The extracellular signal-regulated kinase pathway regulates the phosphorylation of 4E-BP1 at multiple sites. Journal of Biological Chemistry 277, 11591\u201311596, https:\/\/doi.org\/10.1074\/jbc.M110367200 (2002).","journal-title":"Journal of Biological Chemistry"},{"key":"34877_CR16","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1101\/gad.12.4.502","volume":"12","author":"AC Gingras","year":"1998","unstructured":"Gingras, A. C., Kennedy, S. G., O\u2019Leary, M. A., Sonenberg, N. & Hay, N. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev 12, 502\u2013513 (1998).","journal-title":"Genes Dev"},{"key":"34877_CR17","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","volume":"584","author":"CH Jung","year":"2010","unstructured":"Jung, C. H., Ro, S. H., Cao, J., Otto, N. M. & Kim, D. H. mTOR regulation of autophagy. FEBS Lett 584, 1287\u20131295, https:\/\/doi.org\/10.1016\/j.febslet.2010.01.017 (2010).","journal-title":"FEBS Lett"},{"key":"34877_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim, J., Kundu, M., Viollet, B. & Guan, K. L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13, 132\u2013141, https:\/\/doi.org\/10.1038\/ncb2152 (2011).","journal-title":"Nat Cell Biol"},{"key":"34877_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-017-0654-1","volume":"19","author":"A Kalra","year":"2017","unstructured":"Kalra, A. et al. New-Generation Coronary Stents: Current Data and Future Directions. Current atherosclerosis reports 19, 14, https:\/\/doi.org\/10.1007\/s11883-017-0654-1 (2017).","journal-title":"Current atherosclerosis reports"},{"key":"34877_CR20","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/neuonc\/nov152","volume":"17","author":"JP MacKeigan","year":"2015","unstructured":"MacKeigan, J. P. & Krueger, D. A. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex. Neuro Oncol 17, 1550\u20131559, https:\/\/doi.org\/10.1093\/neuonc\/nov152 (2015).","journal-title":"Neuro Oncol"},{"key":"34877_CR21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","volume":"369","author":"J Daemen","year":"2007","unstructured":"Daemen, J. et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369, 667\u2013678, https:\/\/doi.org\/10.1016\/S0140-6736(07)60314-6 (2007).","journal-title":"Lancet"},{"key":"34877_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/heartjnl-2014-305743","volume":"101","author":"N van Boven","year":"2015","unstructured":"van Boven, N. et al. Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEF. Heart 101, 50\u201357, https:\/\/doi.org\/10.1136\/heartjnl-2014-305743 (2015).","journal-title":"Heart"},{"key":"34877_CR23","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1586\/17434440.3.6.731","volume":"3","author":"E Grube","year":"2006","unstructured":"Grube, E. & Buellesfeld, L. BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease. Expert Rev Med Devices 3, 731\u2013741, https:\/\/doi.org\/10.1586\/17434440.3.6.731 (2006).","journal-title":"Expert Rev Med Devices"},{"key":"34877_CR24","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1161\/ATVBAHA.107.156281","volume":"28","author":"T Cyrus","year":"2008","unstructured":"Cyrus, T. et al. Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury. Arteriosclerosis, thrombosis, and vascular biology 28, 820\u2013826, https:\/\/doi.org\/10.1161\/ATVBAHA.107.156281 (2008).","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"34877_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s13233-015-3023-3","volume":"23","author":"JK Park","year":"2015","unstructured":"Park, J. K. et al. Blood-compatible and biodegradable polymer-coated drug-eluting stent. Macromol Res 23, 237\u2013244, https:\/\/doi.org\/10.1007\/s13233-015-3023-3 (2015).","journal-title":"Macromol Res"},{"key":"34877_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0735-1097(92)90476-4","volume":"19","author":"RS Schwartz","year":"1992","unstructured":"Schwartz, R. S. et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. Journal of the American College of Cardiology 19, 267\u2013274 (1992).","journal-title":"Journal of the American College of Cardiology"},{"key":"34877_CR27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0735-1097(97)00450-6","volume":"31","author":"R Kornowski","year":"1998","unstructured":"Kornowski, R. et al. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. Journal of the American College of Cardiology 31, 224\u2013230 (1998).","journal-title":"Journal of the American College of Cardiology"},{"key":"34877_CR28","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1161\/hc3601.093987","volume":"104","author":"T Suzuki","year":"2001","unstructured":"Suzuki, T. et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 104, 1188\u20131193 (2001).","journal-title":"Circulation"},{"key":"34877_CR29","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.molcel.2010.05.017","volume":"38","author":"CK Yip","year":"2010","unstructured":"Yip, C. K., Murata, K., Walz, T., Sabatini, D. M. & Kang, S. A. Structure of the human mTOR complex I and its implications for rapamycin inhibition. Mol Cell 38, 768\u2013774, https:\/\/doi.org\/10.1016\/j.molcel.2010.05.017 (2010).","journal-title":"Mol Cell"},{"key":"34877_CR30","first-page":"3","volume":"1","author":"W Zhu","year":"2009","unstructured":"Zhu, W., Masaki, T., Cheung, A. K. & Kern, S. E. In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation. Journal of bioequivalence & bioavailability 1, 3\u201312 (2009).","journal-title":"Journal of bioequivalence & bioavailability"},{"key":"34877_CR31","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","volume":"25","author":"C Giacinti","year":"2006","unstructured":"Giacinti, C. & Giordano, A. RB and cell cycle progression. Oncogene 25, 5220\u20135227, https:\/\/doi.org\/10.1038\/sj.onc.1209615 (2006).","journal-title":"Oncogene"},{"key":"34877_CR32","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.4161\/cc.5.15.3126","volume":"5","author":"NH Lents","year":"2006","unstructured":"Lents, N. H., Gorges, L. L. & Baldassare, J. J. Reverse mutational analysis reveals threonine-373 as a potentially sufficient phosphorylation site for inactivation of the retinoblastoma tumor suppressor protein (pRB). Cell Cycle 5, 1699\u20131707, https:\/\/doi.org\/10.4161\/cc.5.15.3126 (2006).","journal-title":"Cell Cycle"},{"key":"34877_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrm3025","volume":"12","author":"R Zoncu","year":"2011","unstructured":"Zoncu, R., Efeyan, A. & Sabatini, D. M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nature reviews. Molecular cell biology 12, 21\u201335, https:\/\/doi.org\/10.1038\/nrm3025 (2011).","journal-title":"Nature reviews. Molecular cell biology"},{"key":"34877_CR34","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1046\/j\/1432-1033.2002.03069.x","volume":"269","author":"U Krause","year":"2002","unstructured":"Krause, U., Bertrand, L., Maisin, L., Rosa, M. & Hue, L. Signalling pathways and combinatory effects of insulin and amino acids in isolated rat hepatocytes. Eur J Biochem 269, 3742\u20133750, https:\/\/doi.org\/10.1046\/j\/1432-1033.2002.03069.x (2002).","journal-title":"Eur J Biochem"},{"key":"34877_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.redox.2014.12.007","volume":"4","author":"JK Salabei","year":"2015","unstructured":"Salabei, J. K. & Hill, B. G. Autophagic regulation of smooth muscle cell biology. Redox Biol 4, 97\u2013103, https:\/\/doi.org\/10.1016\/j.redox.2014.12.007 (2015).","journal-title":"Redox Biol"},{"key":"34877_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","volume":"140","author":"N Mizushima","year":"2010","unstructured":"Mizushima, N., Yoshimori, T. & Levine, B. Methods in mammalian autophagy research. Cell 140, 313\u2013326, https:\/\/doi.org\/10.1016\/j.cell.2010.01.028 (2010).","journal-title":"Cell"},{"key":"34877_CR37","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","volume":"109","author":"R Virmani","year":"2004","unstructured":"Virmani, R. et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109, 701\u2013705, https:\/\/doi.org\/10.1161\/01.CIR.0000116202.41966.D4 (2004).","journal-title":"Circulation"},{"key":"34877_CR38","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.2174\/138161210794454941","volume":"16","author":"BE Claessen","year":"2010","unstructured":"Claessen, B. E., Henriques, J. P. & Dangas, G. D. Clinical studies with sirolimus, zotarolimus, everolimus, and biolimus A9 drug-eluting stent systems. Curr Pharm Des 16, 4012\u20134024 (2010).","journal-title":"Curr Pharm Des"},{"key":"34877_CR39","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S0140-6736(12)61852-2","volume":"381","author":"PC Smits","year":"2013","unstructured":"Smits, P. C. et al. Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial. Lancet 381, 651\u2013660, https:\/\/doi.org\/10.1016\/S0140-6736(12)61852-2 (2013).","journal-title":"Lancet"},{"key":"34877_CR40","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(08)61244-1","volume":"372","author":"S Windecker","year":"2008","unstructured":"Windecker, S. et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet 372, 1163\u20131173, https:\/\/doi.org\/10.1016\/S0140-6736(08)61244-1 (2008).","journal-title":"Lancet"},{"key":"34877_CR41","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/ncb2763","volume":"15","author":"CC Dibble","year":"2013","unstructured":"Dibble, C. C. & Manning, B. D. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nat Cell Biol 15, 555\u2013564, https:\/\/doi.org\/10.1038\/ncb2763 (2013).","journal-title":"Nat Cell Biol"},{"key":"34877_CR42","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nature17963","volume":"534","author":"VS Rodrik-Outmezguine","year":"2016","unstructured":"Rodrik-Outmezguine, V. S. et al. Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor. Nature 534, 272\u2013276, https:\/\/doi.org\/10.1038\/nature17963 (2016).","journal-title":"Nature"},{"key":"34877_CR43","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nprot.2016.051","volume":"11","author":"S Forli","year":"2016","unstructured":"Forli, S. et al. Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nature protocols 11, 905\u2013919, https:\/\/doi.org\/10.1038\/nprot.2016.051 (2016).","journal-title":"Nature protocols"},{"key":"34877_CR44","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cell.2011.10.026","volume":"147","author":"N Mizushima","year":"2011","unstructured":"Mizushima, N. & Komatsu, M. Autophagy: renovation of cells and tissues. Cell 147, 728\u2013741, https:\/\/doi.org\/10.1016\/j.cell.2011.10.026 (2011).","journal-title":"Cell"},{"key":"34877_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/cr.2013.168","volume":"24","author":"Y Feng","year":"2014","unstructured":"Feng, Y., He, D., Yao, Z. & Klionsky, D. J. The machinery of macroautophagy. Cell Res 24, 24\u201341, https:\/\/doi.org\/10.1038\/cr.2013.168 (2014).","journal-title":"Cell Res"},{"key":"34877_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/cr.2013.161","volume":"24","author":"P Jiang","year":"2014","unstructured":"Jiang, P. & Mizushima, N. Autophagy and human diseases. Cell Res 24, 69\u201379, https:\/\/doi.org\/10.1038\/cr.2013.161 (2014).","journal-title":"Cell Res"},{"key":"34877_CR47","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1440-1711.2006.01454.x","volume":"84","author":"GH Jia","year":"2006","unstructured":"Jia, G. H., Cheng, G., Gangahar, D. M. & Agrawal, D. K. Insulin-like growth factor-1 and TNF-alpha regulate autophagy through c-jun N-terminal kinase and Akt pathways in human atherosclerotic vascular smooth cells. Immunology and Cell Biology 84, 448\u2013454, https:\/\/doi.org\/10.1111\/j.1440-1711.2006.01454.x (2006).","journal-title":"Immunology and Cell Biology"},{"key":"34877_CR48","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1042\/BJ20121344","volume":"451","author":"JK Salabei","year":"2013","unstructured":"Salabei, J. K. et al. PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress. Biochem J 451, 375\u2013388, https:\/\/doi.org\/10.1042\/BJ20121344 (2013).","journal-title":"Biochem J"},{"key":"34877_CR49","doi-asserted-by":"publisher","first-page":"H1319","DOI":"10.1152\/ajpheart.00160.2012","volume":"303","author":"H Li","year":"2012","unstructured":"Li, H. et al. Sonic hedgehog promotes autophagy of vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 303, H1319\u20131331, https:\/\/doi.org\/10.1152\/ajpheart.00160.2012 (2012).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"34877_CR50","doi-asserted-by":"publisher","first-page":"36112","DOI":"10.1074\/jbc.M703914200","volume":"282","author":"KA Martin","year":"2007","unstructured":"Martin, K. A. et al. Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1\/phosphatidylinositol 3-kinase\/Akt2 feedback signaling. J Biol Chem 282, 36112\u201336120, https:\/\/doi.org\/10.1074\/jbc.M703914200 (2007).","journal-title":"J Biol Chem"},{"key":"34877_CR51","doi-asserted-by":"publisher","first-page":"C507","DOI":"10.1152\/ajpcell.00201.2003","volume":"286","author":"KA Martin","year":"2004","unstructured":"Martin, K. A. et al. The mTOR\/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. Am J Physiol Cell Physiol 286, C507\u2013517, https:\/\/doi.org\/10.1152\/ajpcell.00201.2003 (2004).","journal-title":"Am J Physiol Cell Physiol"},{"key":"34877_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/srep34655","volume":"6","author":"YS Cho","year":"2016","unstructured":"Cho, Y. S. et al. Antidepressant indatraline induces autophagy and inhibits restenosis via suppression of mTOR\/S6 kinase signaling pathway. Sci Rep 6, 34655, https:\/\/doi.org\/10.1038\/srep34655 (2016).","journal-title":"Sci Rep"},{"key":"34877_CR53","first-page":"2415","volume":"13","author":"D Rousseau","year":"1996","unstructured":"Rousseau, D., Gingras, A. C., Pause, A. & Sonenberg, N. The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth. Oncogene 13, 2415\u20132420 (1996).","journal-title":"Oncogene"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34877-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34877-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34877-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:16:47Z","timestamp":1671621407000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34877-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,8]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["34877"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-34877-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,8]]},"assertion":[{"value":"26 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16551"}}